Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

BCAB stock hub

BioAtla, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BCABis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

BCAB

In the news

Latest news · BCAB

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROEn/a

P25 -105.6P50 -46.5P75 -3.1

ROICn/a

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BCAB market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

179

Groups with data

Currency

USD

Showing 179 of 179 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001826892
Company name	BioAtla, Inc.
Country	United States
Country code	US
Cusip	09077B203
Employees	41
Employees Change	-20%
Employees Change Percent	-32.79
Enterprise value	$7.1M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2020-12-16
Isin	US09077B2034
Last refreshed	2026-05-10
Market cap	$8M
Market cap category	Nano-Cap
Price	$4.84
Price currency	USD
Rev Per Employee	48,780.49x
Sector	Healthcare
Sic	2836
Symbol	BCAB
Website	https://www.bioatla.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-743.27%
EV/Sales	3.55x
FCF yield	-601.08%
P/S ratio	4.01x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	$-41.1M
Net Income	$-59.6M
Net Income Growth Quarters	1%
Net Income Growth Years	2%
Pretax Margin	-2,980.35%
Profit Per Employee	$-1.5M
ROA	-110.8
Roa5y	-52.74
ROCE	725.3

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-78.42%
Cagr3y	-70.03%
Cagr5y	-70.96%
EPS Growth Quarters	1
EPS Growth Years	5
Revenue Growth	-81.82x
Revenue Growth Years	0x
Revenue Growth5 Y	36.06x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.06
Assets	$13.8M
Cash	$7.1M
Current Assets	$8M
Current Liabilities	$21.9M
Debt	$6.2M
Equity	$-36.2M
Liabilities	$50M
Long Term Assets	$5.8M
Long Term Liabilities	$28.1M
Net Cash	$918,000
Net Cash By Market Cap	$11.45
Net Cash Growth	-98.1%
Tangible Book Value	$-36.2M
Tangible Book Value Per Share	$-28.51
WACC	4.86

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.37
Net Working Capital	$-19.6M
Quick ratio	0.32
Working Capital	$-13.9M
Working Capital Turnover	$0.18

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-21.11%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-78.39%
200-day SMA	22.64
3Y total return	-97.31%
50-day SMA	6.58
50-day SMA vs 200-day SMA	50under200
5Y total return	-99.79%
All Time High	3,831.5
All Time High Change	-99.87%
All Time High Date	2021-03-19
All Time Low	3.92
All Time Low Change	23.47%
All Time Low Date	2026-04-07
ATR	0.67
Beta	0.79
Beta1y	0.04
Beta2y	1.98
Ch YTD	-82.95
High	5.18
High52	71.5
High52 Date	2025-11-19
High52ch	-93.23%
Low	4.36
Low52	3.92
Low52 Date	2026-04-30
Low52ch	23.47%
Ma50ch	-26.48%
Price vs 200-day SMA	-78.62%
RSI	45.2
RSI Monthly	33.43
RSI Weekly	32.92
Sharpe ratio	-0.47x
Sortino ratio	-0.62
Tr YTD	-82.95
Tr1m	3.86%
Tr1w	13.35%
Tr3m	-54.04%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	1
Analyst Ratings	Hold
Earnings EPS Estimate	$-0.37
Operating Income	$-58.7M
Operating margin	-2,935.3

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,383,058%
Float Percent	83.47%
Net Borrowing	7,125,000
Shares Insiders	7.3%
Shares Institutions	11.05%
Shares Out	1,656,926
Shares Qo Q	1.79%
Shares Yo Y	21.11%
Short Float	8.19%
Short Ratio	2.48
Short Shares	6.84

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-53.6M
Average Volume	38,128.5x
Bv Per Share	-28.51
Ch1m	3.86
Ch1w	13.35
Ch1y	-78.39
Ch3m	-54.04
Ch3y	-97.31
Ch5y	-99.79
Ch6m	-85.9
Change	11.26%
Change From Open	11.01
Close	4.35
Days Gap	0.23
Depreciation Amortization	373,000
Dollar Volume	282,293
Earnings Date	2026-05-22
Earnings Time	amc
EBIT	$-58.7M
EBITDA	$-58.3M
EPS	$-50.66
F Score	1
FCF	$-48.2M
FCF EV Yield	-678.78x
FCF Per Share	$-29.09
Financing CF	6,276,000
Fiscal Year End	December
Founded	2,007
Ipr	-73.11
Iprfo	-99.68
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-31
Last Report Date	2025-12-31
Last Split Date	2026-04-06
Last Split Type	Reverse
Last10k Filing Date	2026-03-31
Ma150	21.91
Ma150ch	-77.91%
Ma20	4.69
Ma20ch	3.11%
Net CF	-41,928,000
Next Earnings Date	2026-05-22
Open	4.36
Optionable	Yes
Position In Range	58.54
Post Close	4.84
Postmarket Change Percent	-0.72
Postmarket Price	$4.81
Ppne	5,652,000
Price Date	2026-05-08
Relative Volume	1.53x
Revenue	2,000,000x
SBC By Revenue	271.7x
Share Based Comp	5,434,000
Tr6m	-85.9%
Us State	California
Volume	58,325
Z Score	-69.95

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does BCAB pay a dividend?

Capital-return profile for this ticker.

Performance

BCAB stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BCAB?

Insider, institutional, and short-interest positioning.

Institutional ownership

+11.0%

Float: +83.5% of shares outstanding

Insider ownership

+7.3%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

BCAB momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

45.2

Neutral momentum band

Price vs 200-day MA

-78.6%

50/200-day relationship not available

Beta (5Y)

0.79

Less volatile than the market

Sharpe ratio

-0.47

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BCAB

Hub-level FAQ points readers to the deeper analysis pages.

What is the current BCAB stock rating?

BioAtla, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full BCAB analysis?

The full report lives at /stocks/BCAB/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for BCAB?

The latest report frames BCAB around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the BCAB page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.